Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoffer W Tornøe

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|September 22, 2005
Non-linear mixed-effects models with stochastic differential equations: implementation of an estimation algorithmRune V Overgaard, Niclas Jonsson, Christoffer W Tornøe, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 13, 2006
Semi-mechanistic pharmacodynamic modeling for degarelix, a novel gonadotropin releasing hormone (GnRH) blockerPravin R Jadhav, Henrik Agersø, Christoffer W Tornøe, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 27, 2005
Grey-box modelling of pharmacokinetic/pharmacodynamic systemsChristoffer W Tornøe, Judith L Jacobsen, Oluf Pedersen, et al.
Journal of Clinical Pharmacology|January 14, 2011
Population pharmacokinetic and concentration--QTc models for moxifloxacin: pooled analysis of 20 thorough QT studiesJeffry A Florian, Christoffer W Tornøe, Richard Brundage, et al.
Computer Methods and Programs in Biomedicine|August 18, 2004
Non-linear mixed-effects pharmacokinetic/pharmacodynamic modelling in NLME using differential equationsChristoffer W Tornøe, Henrik Agersø, E Niclas Jonsson, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 14, 2005
Pharmacokinetic/pharmacodynamic modelling of GnRH antagonist degarelix: a comparison of the non-linear mixed-effects programs NONMEM and NLMEChristoffer W Tornøe, Henrik Agersø, Henrik A Nielsen, et al.
Pharmaceutical Research|May 14, 2004
Population pharmacokinetic modeling of a subcutaneous depot for GnRH antagonist degarelixChristoffer W Tornøe, Henrik Agersø, Henrik A Nielsen, et al.
Journal of Clinical Pharmacology|October 28, 2010
Creation of a knowledge management system for QT analysesChristoffer W Tornøe, Christine E Garnett, Yaning Wang, et al.
Pharmaceutical Research|August 4, 2005
Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equationsChristoffer W Tornøe, Rune V Overgaard, Henrik Agersø, et al.
British Journal of Clinical Pharmacology|November 14, 2006
Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic-pituitary-gonadal axis following treatment with GnRH analoguesChristoffer W Tornøe, Henrik Agersø, Thomas Senderovitz, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Pharmacokinetics and Pharmacodynamics|September 22, 2005
Non-linear mixed-effects models with stochastic differential equations: implementation of an estimation algorithmRune V Overgaard, Niclas Jonsson, Christoffer W Tornøe, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 13, 2006
Semi-mechanistic pharmacodynamic modeling for degarelix, a novel gonadotropin releasing hormone (GnRH) blockerPravin R Jadhav, Henrik Agersø, Christoffer W Tornøe, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 27, 2005
Grey-box modelling of pharmacokinetic/pharmacodynamic systemsChristoffer W Tornøe, Judith L Jacobsen, Oluf Pedersen, et al.
Journal of Clinical Pharmacology|January 14, 2011
Population pharmacokinetic and concentration--QTc models for moxifloxacin: pooled analysis of 20 thorough QT studiesJeffry A Florian, Christoffer W Tornøe, Richard Brundage, et al.
Computer Methods and Programs in Biomedicine|August 18, 2004
Non-linear mixed-effects pharmacokinetic/pharmacodynamic modelling in NLME using differential equationsChristoffer W Tornøe, Henrik Agersø, E Niclas Jonsson, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 14, 2005
Pharmacokinetic/pharmacodynamic modelling of GnRH antagonist degarelix: a comparison of the non-linear mixed-effects programs NONMEM and NLMEChristoffer W Tornøe, Henrik Agersø, Henrik A Nielsen, et al.
Pharmaceutical Research|May 14, 2004
Population pharmacokinetic modeling of a subcutaneous depot for GnRH antagonist degarelixChristoffer W Tornøe, Henrik Agersø, Henrik A Nielsen, et al.
Journal of Clinical Pharmacology|October 28, 2010
Creation of a knowledge management system for QT analysesChristoffer W Tornøe, Christine E Garnett, Yaning Wang, et al.
Pharmaceutical Research|August 4, 2005
Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equationsChristoffer W Tornøe, Rune V Overgaard, Henrik Agersø, et al.
British Journal of Clinical Pharmacology|November 14, 2006
Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic-pituitary-gonadal axis following treatment with GnRH analoguesChristoffer W Tornøe, Henrik Agersø, Thomas Senderovitz, et al.
Pageof 2